Search results
Results from the WOW.Com Content Network
MD Anderson Services Corporation [102] (formerly MD Anderson Cancer Center Outreach Corporation [103]) was established in 1989 as a not-for-profit corporation to enhance revenues of The University of Texas MD Anderson Cancer Center by establishing joint ventures in selected markets, providing additional referrals to the institution, contracting ...
Singletary stayed at MD Anderson as a faculty member, later serving as chief of the melanoma surgery and breast surgery sections. Her interest in breast cancer was influenced by MD Anderson radiation oncologist Eleanor Montague. [2] In 1992, the President's Cancer Panel appointed her to a special committee that examined the state of breast ...
Gibbs was selected to be an NCI-funded clinical oncology programs in 1983 and has been continuously funded by NCI for thirty years. Gibbs Cancer Center became an exclusive host affiliate of the MD Anderson Cancer Center in 2005 and established the Bearden-Josey Center for Breast Health in 2008.
Dr. Debra Patt, an oncologist and breast cancer specialist in Austin, Texas, and the medical director for public policy at the U.S. Oncology Network, has testified before Congress about the ...
Triple-positive breast cancers are among the more aggressive forms of the disease, but they’re also the most treatable variety, according to MD Anderson Cancer Center. When a tumor is “triple ...
Virgil Craig Jordan, CMG, OBE, FMedSci, (July 25, 1947 – June 9, 2024) was an American and British scientist specializing in drugs for breast cancer treatment and prevention. [1] He was Professor of Breast Medical Oncology, and Professor of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas.
"I do agree that alcohol guidelines should be updated to include cancer risks," Dr. Nilesh L. Vora, MD, board-certified hematologist and medical oncologist and medical director of the MemorialCare ...
Gordon B. Mills is the Wayne and Julie Drinkward Endowed Chair in Precision Oncology, Director of Precision Oncology, Director of SMMART Trials and Professor in Cell, Development and Cancer Biology in the Knight Cancer Institute at Oregon Health & Science University. He is most well known for his discoveries in the PI3K pathway in breast cancer ...